Clinical Trials
All Clinical Trials - Page 29 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03061214Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
Semaglutide
- NCT03996837N/ACompleted
Platelet Rich Plasma and Recurrent Implantation Failure
Gonadorelin
- NCT03070704N/AWithdrawn
Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
Liraglutide
- NCT03182426Phase 1/Phase 2Completed
Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
Liraglutide
- NCT03520062N/ACompleted
The Effect of Liraglutide on Pancreatic Hormones and Its Size
Liraglutide
- NCT03232112Phase 2Completed
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
Exenatide
- NCT03235050Phase 2Completed
A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Liraglutide
- NCT03804411Phase 4Unknown
Prognostic Predictors of Response to Hypoglycemic Therapy
Liraglutide
- NCT02553603Phase 1Completed
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
Tesamorelin
- NCT04555824Phase 1Completed
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
TB-500
- NCT03208881N/AUnknown
Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness
Liraglutide
- NCT03017313N/ACompleted
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients
Gonadorelin
- NCT03098797Phase 2/Phase 3Completed
A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome
Elamipretide
- NCT03151005Phase 4Completed
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Liraglutide
- NCT02907918Phase 2Terminated
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Gonadorelin
- NCT03175211Phase 1Completed
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
Survodutide
- NCT03191396Phase 3Completed
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
Semaglutide
- NCT03204396Phase 2Completed
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
Dulaglutide
- NCT03093272Phase 2Terminated
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Gonadorelin
- NCT03115424Phase 3Completed
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Liraglutide
- NCT03139474Phase 2/Phase 3Unknown
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
Gonadorelin
- NCT03353883Phase 2/Phase 3Unknown
Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?
Gonadorelin
- NCT03192527Phase 1Unknown
Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers
Gonadorelin
- NCT03115099Phase 1Completed
A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
Liraglutide
- NCT03172494Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Liraglutide
- NCT03175120Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
Liraglutide
- NCT03131687Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Tirzepatide
- NCT03167411Phase 1Completed
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Exenatide
- NCT03048578Phase 4Completed
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Liraglutide
- NCT03007732Phase 2Completed
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Gonadorelin
- NCT02960659Phase 1/Phase 2Completed
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
Liraglutide
- NCT03497702Phase 2Unknown
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
Gonadorelin
- NCT03142893Phase 1Active Not Recruiting
Hormonal Mechanisms of Sleep Restriction - Axis Study
Gonadorelin
- NCT03101930Phase 4Completed
Cardiovascular Effects of GLP-1 Receptor Activation
Liraglutide
- NCT03158805Phase 2Completed
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
Liraglutide
- NCT03085095Phase 3Completed
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Gonadorelin
- NCT03082885N/ACompleted
The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF
Thymosin-Alpha-1
- NCT02953665Phase 2Completed
Safety and Efficacy of Liraglutide in Parkinson's Disease
Liraglutide
- NCT03824002Phase 4Completed
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Dulaglutide
- NCT03016741Phase 4Active Not Recruiting
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Gonadorelin
- NCT03136484Phase 3Completed
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Semaglutide
- NCT03007329Phase 4Completed
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Exenatide
- NCT03009981Phase 3Completed
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Gonadorelin
- NCT02964247Phase 3Completed
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Liraglutide
- NCT03060980Phase 3Terminated
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Exenatide
- NCT03071172Phase 3Unknown
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Gonadorelin
- NCT03043807Phase 2Completed
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Gonadorelin
- NCT02735031Phase 2/Phase 3Completed
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Exenatide
- NCT03041792Phase 1Completed
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
Liraglutide
- NCT02572323Phase 2Completed
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Tesamorelin